Kamada Ltd (KMDA)

Dec 28, 2025

Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat

Dec 28, 2025

Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat

Dec 23, 2025

Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World

Dec 23, 2025

Dec 23, 2025

Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN

Dec 23, 2025

Dec 22, 2025

Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 22, 2025

Dec 21, 2025

Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда

Dec 20, 2025

Dec 19, 2025

Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда

Dec 19, 2025

Dec 19, 2025

Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks

Dec 19, 2025

Dec 18, 2025

Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда

Dec 18, 2025

Dec 18, 2025

Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда

Dec 18, 2025

Dec 18, 2025

Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria

Dec 18, 2025

Dec 18, 2025

Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks

Dec 18, 2025

Dec 18, 2025

Kamada secures $10-14 million Canadian supply tender extension - Investing.com

Dec 18, 2025

Dec 18, 2025

Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan

Dec 18, 2025

Dec 18, 2025

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire

Dec 18, 2025

Dec 18, 2025

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN

Dec 18, 2025

Dec 18, 2025

Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN

Dec 18, 2025

Dec 15, 2025

Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn

Dec 15, 2025

Dec 13, 2025

Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily

Dec 13, 2025

Dec 13, 2025

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

Dec 13, 2025

Dec 12, 2025

FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World

Dec 12, 2025

Dec 11, 2025

What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat

Dec 11, 2025

Dec 11, 2025

Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World

Dec 11, 2025

Dec 11, 2025

HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World

Dec 11, 2025

Dec 10, 2025

Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Dec 10, 2025

Dec 10, 2025

Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat

Dec 10, 2025

Dec 09, 2025

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria

Dec 09, 2025

Dec 09, 2025

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 08, 2025

Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga

Dec 08, 2025

Dec 08, 2025

Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com

Dec 08, 2025

Dec 08, 2025

Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks

Dec 08, 2025

Dec 08, 2025

Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks

Dec 08, 2025

Dec 08, 2025

Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks

Dec 08, 2025

Dec 08, 2025

Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus

Dec 08, 2025

Dec 08, 2025

Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com

Dec 08, 2025

Dec 08, 2025

Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView

Dec 08, 2025

Dec 08, 2025

Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial - Investing.com

Dec 08, 2025

Dec 08, 2025

Kamada (NASDAQ: KMDA) drops inhaled AAT study, reaffirms $178M-$182M 2025 revenue - Stock Titan

Dec 08, 2025

Dec 04, 2025

Shareholders May Not Be So Generous With Kamada Ltd.'s (TLV:KMDA) CEO Compensation And Here's Why - simplywall.st

Dec 04, 2025

Dec 03, 2025

Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat

Dec 03, 2025

Dec 03, 2025

Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World

Dec 03, 2025

Dec 02, 2025

Technical Reactions to KMDA Trends in Macro Strategies - news.stocktradersdaily.com

Dec 02, 2025

Dec 02, 2025

Kamada updates proxy statement ahead of annual shareholder meeting By Investing.com - Investing.com Australia

Dec 02, 2025

Dec 02, 2025

Kamada updates proxy statement ahead of annual shareholder meeting - Investing.com

Dec 02, 2025